Significance of Earlier Initiation of Chemotherapy for Lung Cancer Complicated with Primary or Secondary Nephrotic Syndrome following Its Appropriate Differential Diagnosis
暂无分享,去创建一个
S. Ota | Y. Fujigaki | T. Honda | N. Seki | K. Kojima | Yoshifuru Tamura | S. Tanzawa | Kiyotaka Watanabe | M. Ishihara | R. Ochiai | Terunobu Haruyama | Takahiko Sakamoto | Y. Ichikawa | M. Natsume | Y. Fukasawa | R. Usui
[1] S. Kirsa,et al. Guidelines for timely initiation of chemotherapy: a proposed framework for access to medical oncology and haematology cancer clinics and chemotherapy services , 2016, Internal medicine journal.
[2] O. Arrieta,et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study , 2010, BMC Cancer.
[3] Mats O Karlsson,et al. Population Pharmacokinetic-Pharmacodynamic Model for Neutropenia with Patient Subgroup Identification: Comparison across Anticancer Drugs , 2006, Clinical Cancer Research.
[4] G. Lyman,et al. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP‐R, or CNOP chemotherapy for intermediate‐grade non‐Hodgkin lymphoma , 2003, Cancer.
[5] F. Goldwasser,et al. Evaluation of the nutritional and inflammatory status in cancer patients for the risk assessment of severe haematological toxicity following chemotherapy. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] N. Milman,et al. Prevalence and prognostic significance of proteinuria in patients with lung cancer. , 1996, Acta oncologica.
[7] M. Haas,et al. IgG subclass deposits in glomeruli of lupus and nonlupus membranous nephropathies. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[8] M. Schwartz,et al. Membranous glomerulonephritis and malignancy. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] J. Crowley,et al. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] M. Averbuch,et al. Nephrotic syndrome complicating adenocarcinoma of the lung with resolution after resection. , 1991, The Annals of thoracic surgery.
[11] Y. Hamashima,et al. Distribution of IgG subclasses in membranous nephropathy. , 1984, Clinical and experimental immunology.
[12] K E Stanley,et al. Prognostic factors for survival in patients with inoperable lung cancer. , 1980, Journal of the National Cancer Institute.
[13] J. Lee,et al. The association of cancer and the nephrotic syndrome. , 1966, Annals of internal medicine.